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Background: To date, only a few studies on child obesity concerned Trace Elements (TE). TE is involved in the
pathogenesis of obesity and obesity related diseases. We tried to assess trace elements status [zinc (Zn), copper
(Cu), selenium (Se), iron (Fe), and chromium (Cr)] in obese Egyptian children and their relationships with serum
leptin and metabolic risk factors of obesity.
Methods: This was a case–control study performed with 80 obese children (BMI ≥ 95thcentile for age and gender)
and 80 healthy non-obese children with comparable age and gender as the control group. For all subjects, serum
Zn, Cu, Se, Fe, ferritin and Cr as well as biochemical parameters including lipid profile, serum glucose and homeostasis
model assessment of insulin resistance (HOMA-IR) were assessed. Levels of serum leptin were measured by (enzyme-
linked immunosorbent assay [ELISA] method), and serum insulin was measured by an electrochemiluminesce
immunoassay.
Results: Compared to the control group, serum Zn, Se, and Fe levels were significantly lower (all P < 0.01) and serum
Cu level was significantly higher (P < 0.01) in the obese children. Meanwhile, no significant differences were observed
in serum ferritin or Cr levels (P > 0.05). A significant negative correlation was found between serum leptin and zinc
levels in the obese children (r = −0.746; P < 0.01). Further, serum Zn showed significant negative correlations with total
cholesterol TC levels (P < 0.05) and were positively correlated with high density lipoprotein- cholesterol HDL-C levels
(P < 0.01) in the obese children. In addition, serum Se levels showed significant positive correlations with HOMA-IR
values in the obese children (P < 0.01).
Conclusion: The obese children may be at a greater risk of developing imbalance (mainly deficiency) of trace elements
which may be playing an important role in the pathogenesis of obesity and related metabolic risk factors.
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Childhood obesity has been called “one of the most ser-
ious public health challenges of the 21st century” [1].
According to the report of International Obesity Task
Force (IOTF), in the year 2000 about 10% (a total of 155
million) of the young people aged 5–17 years globally
were overweight; among whom 2-3% (30–45 million)
were obese, a further 22 million younger children are
also affected according to previous IOTF global estimates
based on WHO data for under-fives [2,3]. Developing
countries are facing the double burden of nutritional tran-
sition, i.e. malnutrition and micronutrient deficiencies as* Correspondence: Seham_Azab@yahoo.com
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[4]. Genetic factors, environmental factors, lifestyle prefer-
ences, and cultural factors seem to play major role in the
rising prevalence of obesity worldwide [5,6]. Leptin, a
16 kDa neurohormone predominantly synthesized and re-
leased into blood by adipocytes and serves as a signal for
the brain of the body’s energy store. Leptin controls food
intake through its receptors in the hypothalamus by inhi-
biting the release of NPY which has an augmentative ef-
fect on food intake. By reducing food intake and
increasing thermogenesis, leptin is a key hormone in the
regulation of body weight and nutrition [7]. Interest in
trace elements has been steadily increasing over the last
25 years. Trace elements are essential nutrients with regu-
latory, immunologic, and antioxidant functions resultingd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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enzymes throughout metabolism [8]. To date, only a few
studies on child obesity concerned Trace Elements (TE).
TE are involved in the production of or in the protection
against inflammation and peroxidation which are key fac-
tors in the development of the metabolic complications of
obesity, arterial hypertension, dyslipidemia and insulin re-
sistance or diabetes [9]. Therefore, it is important to know
and measure trace elements status in children because the
alterations in the content may play an important role in
the pathogenesis of obesity and related metabolic risk fac-
tors. In this study, we aimed to estimate serum trace ele-
ments status [zinc (Zn), copper (Cu), selenium (Se), iron
(Fe), and chromium (Cr)] in obese Egyptian children in
comparison with normal weight controls. Further, correla-
tions between serum trace elements levels and body mass
index (BMI), serum leptin, lipid profile, fasting glucose, in-
sulin and homeostasis model assessment of insulin resist-
ance (HOMA-IR) were also determined in these children.
Methods
This was a case–control study performed in Zagazig
University Children Hospital Outpatient Clinics from
May 2011 to April 2013. Subjects were children attend-
ing the specialized obesity outpatient clinic of Zagazig
University Hospital. They were all apparently healthy
with no obvious endocrine disease. Our study included
80 obese subjects with BMI ≥ 95th centile for age and sex
(36 girls and 44 boys). The age of the obese children
ranged from 5.5 to 10 years (mean, 7.8 years). Eighty
non obese children of comparable age and sex who were
found healthy after the evaluation in pediatric clinics
were included as controls.
Exclusion criteria
Children with syndromal obesity, endocrine disorders,
any physical disability, history of chronic medication use,
use of mineral and/or vitamin supplements, history of
any chronic diseases and/or chronic medication use or
children under special diets were not included in the
study.
A detailed medical and family history was obtained from
all subjects. At enrollment, obese and control subjects
underwent physical examination including weight, stand-
ing height, BMI, and blood pressure measurements.
Anthropometrics
Height was measured without shoes using a Harpenden
stadiometer (Harpenden, Holtain Ltd., UK) to the near-
est 0.1 cm. Weight was measured to the nearest 0.1 kg
on a standard beam scale with the subject dressed only
in light underwear and without shoes. The waist circum-
ference was measured at its smallest point between the
iliac crest and rib cage, and the hip circumference wasmeasured at its largest width over the greater trochan-
ters. All the measurements were repeated twice. The
weight status was recorded as the BMI, calculated as fol-
lows: BMI = weight (kg)/height(m)2. Because the BMI
varies according to age, we standardized the value for
age and sex by converting to a “z score” [10] and ex-
pressed the value as the BMI-SDS, which was calculated
as follows: BMI-SDS = [individual measurement − popu-
lation mean]/population SD. Overweight was defined as
BMI between 1 and 1.99 SD and obesity above 2 SD.
The distribution of fat mass was expressed by the waist-
to-hip ratio (waist circumference/hip circumference).
Pubertal stage was assessed according to Tanner cri-
teria. All our subjects (obese and control groups) were
in the pre-pubertal stage (boys with pubic hair and go-
nadal stage I, girls with pubic hair and breast stage I).
Biochemical analysis
On the first visit after enrollment, blood sample was
drawn after an overnight fast from both groups. Serum
lipids, glucose and insulin levels were measured immedi-
ately. Blood samples were drawn using metal-free and
stainless steel needles into appropriately coated tubes
(Becton Dickinson Laboratories, Franklin Lakes, NJ,
USA) for measurement of serum levels of zinc, copper,
selenium, iron, and chromium in obese and control chil-
dren. The tubes were centrifuged at 2,000 × g for 10 mi-
nutes and the samples were tested for trace elements
using Inductively Coupled Plasma mass-spectrometry
(ICP-MS) (Perkin Emler Optima 4300, DV, USA) [11].
Serum Ferritin was analyzed by an immuno-assay (Elecsys,
Boehringer Manneim, France).
Serum leptin and insulin measurement
Serum Leptin was detected with commercially available
test kits were used to measure leptin (enzyme-linked im-
munosorbent assay [ELISA] method, DRG International,
Mountainside, NJ, USA), that has a range of 0.25.120 ng/mL.
The DRG Leptin ELISA is an enzyme immunoassay for
the measurement of leptin in serum and plasma. In the
DRG Leptin ELISA the following values are observed:
males 3.84 ± 1.79 ng/mL, females 7.36 ± 3.73 ng/Ml [12].
Fasting serum insulin was measured by electrochemilumi-
nescence immunoassay using Cobas e 411 immunoassay
analyzer (Roch Diagnostics, GmbH, German). Fasting
glucose, total cholesterol (TC) and triglycerides (TGs)
concentrations were determined in plasma with commer-
cial kits (Elitech, Sees, France) using a clinical chemical
analyzer (Bayer RA-50, Bayer Diagnostics, Dulin, Ireland).
Both, high density lipoprotein- cholesterol (HDL-C) and
low density lipoprotein- cholesterol (LDL-C) were mea-
sured by spectrophotometry (Genesis 20 ThermoSpectronic,
Thermo Electron Corp, Madison, WI) with commercially
available kits (Cholesterol HDL, Elitech, Sees, France;







Serum zinc (ug/dl) 57 ± 14 75 ± 17 <0.01a
Serum copper (ug/dl) 123.7 ± 28 96.4 ± 23 <0.01a
Serum selenium (ug/L) 63.6 ± 15 78.3 ± 18 <0.01a
Serum iron (ug/dl) 46.8 ± 11 63.5 ± 13 <0.01a
a
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High total cholesterol with concentrations >200 mg/dL,
high LDL with concentrations > 100 mg/dL, high triglycer-
ides with concentrations >150 mg/dL, and low HDL with
concentrations <50 mg/dL [13].
The homeostasis model assessment of insulin resist-
ance was calculated with the following formula (HOMA ‐
IR) = [fasting insulin (uU/ml) × fasting glucose (mmol/L)]/
22.5 [14].
Ethics
Informed parental consent was obtained to be eligible
for enrollment into the study. The study was done ac-
cording to the rules of the Local Ethics Committee of
Faculty of Medicine, Zagazig University, Egypt.
Statistical methods
SPSS version 19 and EPI-info Version 6.04 were used for
data analysis. The data are expressed as the mean ± SD
or median (min-max) where appropriate. Test selection
was based on evaluating the variables for normal distri-
bution using the Shapiro-Wilk test. If the variables had a
normal distribution, Student’s t-test was used. If the vari-
able did not have a normal distribution, the analysis was
done using the Mann–Whitney U test. Categorical data
were evaluated by Pearson’s chi-square test. Statistical
correlations were calculated by Pearson’s correlation test.
P < 0.05 was considered significant.
Results
Our study included 80 obese subjects (36 girls and 44
boys, mean age 7.8 ± 2.3 years, mean body mass index
[BMI] 28.8 ± 2.6 kg/m2, mean BMI- z score 3.7 ± 0.6, all
pre-pubertal stage) and 80 non-obese control subjects
(40 girls and 40 boys, mean age 8.1 ± 1.9 years, mean
BMI 16.2 ± 2.4 kg/m2, mean BMI- z score 0.32 ±0.4, all
pre-pubertal stage) whose clinical characteristics are
listed in Table 1. The obesity and control groups showed







Age (years) 7.8 ± 2.3 8.1 ± 1.9 >0.05a
Male/female 44(55%)/36(45%) 40(50%)/40(50%) >0.05b
BMI (kg/m2) 28.8 ± 2.6 16.2 ± 2.4 <0.01a
BMI z score 3.7 ± 0.6 0.32 ±0.4 <0.01a
Waist circumference (cm) 87.5 ± 8.7 59.6 ± 7.6 <0.01a
Hip circumference (cm) 97.3 ± 5.4 73.5 ± 4.8 <0.01a
Waist/hip ratio 0.89 ± 0.06 0.81 ± 0.05 <0.01a
BMI, body mass index; Values are mean ± standard deviations. aStudent’s t-test.
bChi-square test. P value < 0.05 indicates a significant difference.(P > 0.05). Compared to the controls, the obese children
demonstrated significant differences in a number of clin-
ical risk factors including body weight, BMI, BMI- z score,
waist circumference, hip circumference, and waist/hip ra-
tio (all p < 0.01; Table 1).
Serum Cu levels, triglycerides, total cholesterol, LDL-C,
fasting blood glucose, fasting blood insulin, and HOMA-
IR in obese children were significantly higher (all P <
0.01), whereas serum Zn, Se, Fe levels and HDL-
cholesterol, were significantly lower than those of healthy
controls (all P < 0.01). However, no significant differences
were observed in serum ferritin or Cr levels between both
groups (P > 0.05; Table 2). Serum leptin was significantly
higher in the obese children compared to the control
group (25.6 ± 3.2 vs 9.3 ± 1.5 ng/mL; P < 0.01) (Table 2).
The obese children had significantly lower median
serum zinc, selenium and iron levels compared to non-
obese controls (57 ± 14 vs 75 ± 17 ug/dl); (63.6 ± 15 vs
78.3 ± 18 ug/L); and (46.8 ± 11 vs 63.5 ± 13 ug/dl); re-
spectively (all P < 0.01) (Figure 1A, B, C) respectively.
Simple correlation analyses were performed to investi-
gate the association of serum trace elements levels with
BMI and serum leptin level among studied subjects. The
BMI was positively correlated with serum leptin level (r =
0.539, P < 0.01). Both serum Zn and iron levels showed
significant negative correlations with BMI (r = −0.646, P <
0.01 and r = −0.479, P < 0.05; respectively) in the obese
children. On the other hand, no significant correlations
were found between serum Cu, Se or Cr levels and BMI in
the obese children (all P > 0.05; Table 3).Serum ferritin (ng/ml) 68.5 ± 11.2 71.6 ± 10.6 >0.05
Serum chromium (ng/ml) 0.2 ± 0.08 0.18 ± 0.05 >0.05a
Triglycerides (mg/dl) (294–68)173 (155–45)83 <0.01c
Total cholesterol (mg/dl) (312–105)183 (178–67)98 <0.01c
LDL- cholesterol (mg/dl) (228–43)97 (105–39)73 <0.01c
HDL- cholesterol (mg/dl) (72–17)33 (91–40)56 <0.01c
Fasting glucose (mg/dl) 93.5 ± 8.3 81.5 ± 7.7 <0.01a
Fasting insulin (uU/ml) 13.8 ± 1.2 6.3 ± 0.8 <0.01a
HOMA-IR 3.1 ± 0.8 1.3 ± 0.5 <0.01a
Serum leptin (ng/mL) 25.6 ± 3.2 9.3 ± 1.5 <0.01a
LDL, low density lipoprotein; HDL, High density lipoprotein; HOMA-IR,
homeostasis model assessment of insulin resistance. Values are mean ± standard
deviations or median (minimum- maximum). P value < 0.05 indicates a significant















































Serum zinc level among studied subjects
(p<0.01)
Serum selenium level among studied subjects
(p<0.01)
Figure 1 Serum zinc, selenium, and iron level among studied subjects. A Serum zinc level among studied subjects. B Serum selenium level
among studied subjects. C Serum iron level among studied subjects.
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with serum zinc levels in the obese children (r = −0.746;
P < 0.01). On the other hand, no significant correlations
were observed between serum leptin and serum Cu, Se,
Fe or Cr levels in the obese children (all P > 0.05;
Table 3).Table 3 Correlations of serum trace elements levels with
BMI and serum leptin in the obese children
Body mass index Serum leptin
r p r p
BMI (kg/m2) - - 0.539 <0.01
Serum leptin (ng/mL) 0.539 <0.01 - -
Serum zinc (ug/dl) −0.646 <0.01 −0.746 <0.01
Serum copper (ug/dl) 0.112 >0.05 −0.245 >0.05
Serum selenium (ug/l) −0.108 >0.05 −0.078 >0.05
Serum iron (ug/dl) −0.479 <0.05 −0.245 >0.05
Serum chromium (ng/ml) −0.063 >0.05 −0.078 >0.05
BMI, body mass index. Values are Correlation coefficient r (Pearson’s Correlation
analysis). P value < 0.05 indicates a significant difference.On the contrary, no significant correlations were ob-
served between BMI or serum leptin and studied trace
elements in the non-obese controls (all P > 0.05).
To maximize the clarity in Tables 4 and 5 only statisti-
cally significant coefficients were included.
In the obese children, serum Zn showed significant
negative correlations with serum TC levels (r = −0.454,
P < 0.05; Table 4). Otherwise, serum Zn levels showed
significant positive correlation with HDL-C levels (r =
0.608, P < 0.01). By contrast, no significant correlation
was found between serum Cu, Se, Fe or Cr levels and
lipid profile in the obese children (all P > 0.05; Table 4).
Serum Zn levels were negatively correlated with fast-
ing glucose levels and HOMA-IR values in the obese
children (r = −0.326, P < 0.05 and r = −0.469, P < 0.05; re-
spectively; Table 5). Of note, serum Se levels showed sig-
nificant positive correlations with HOMA-IR values in
the obese children (r = 0.635, P < 0.01). On the other
hand, no significant correlation was found between
serum Cu, Fe or Cr levels and glycaemia control param-
eters in the obese children (all P > 0.05; Table 5).
Table 4 Correlations of serum trace elements with lipid profile in the obese children and non-obese controls
Obese children (n=80) Controls (n=80)
TGs TC LDL-C HDL-C TGs TC LDL-C HDL-C
Serum zinc −0.268 −0.454* −0.254 0.608** −0.056 −0.115 −0.098 0.197
Serum copper 0.193 0.038 0.078 −0.153 0.137 0.069 0.037 −0.067
Serum selenium −0.148 −0.197 −0.165 0.234 −0.091 −0.087 −0.165 0.184
Serum iron 0.094 0.158 0.186 −0.211 0.038 0.105 0.143 −0.178
Serum chromium −0.135 −0.118 −0.156 0.209 −0.112 −0.087 −0.068 0.149
TGs, triglycerides; TC, total cholesterol; LDL-C, low density lipoprotein- cholesterol; HDL-C, High density lipoprotein- cholesterol. Values are Correlation coefficient r
(Pearson’s Correlation analysis). *P < 0.05; **P < 0.01.
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Recent evidence suggests that deficiencies of some micro-
nutrients are related to obesity and fat deposition [15].
Few studies about the role of Zn in childhood obesity were
published [16,17]. Some demonstrated a reduction in
serum concentration of zinc in obese children [18]. Our
study confirms the significantly lower serum Zn level in
the obese children compared to the non-obese controls
(57 ± 14 vs 75 ± 17 ug/dl; P < 0.01). Further, we observed a
significant negative correlation between serum leptin and
zinc levels in the obese children (r = −0.746; P < 0.01).
Zinc, in particular, takes part in the metabolism of hor-
mones involved in the pathophysiology of obesity. It has
been observed that zinc concentration is directly associ-
ated with serum leptin concentration, an adipokine associ-
ated with satiety [19]. This association could be explained
by the effect of zinc-α2-glycoprotein (ZAG) on leptin con-
centrations. ZAG is an adipokine involved in lipolysis in
the adipocyte that is down-regulated in obesity. In obese
individuals, low ZAG gene expression is associated with
low serum adiponectin and high plasma leptin levels, and
may play an important role in the pathogenesis of obesity
[20]. Chen et al., suggested in their study that leptin resist-
ance that occurred in obesity might have resulted from
zinc deficiency [21]. On the contrary, no differences were
observed in zinc concentrations between obese and non-




Serum zinc −0.326* −0.235 −
Serum copper −0.105 −0.285 −
Serum selenium 0.203 0.119 0
Serum iron −0.181 −0.154 −
Serum chromium 0.143 −0.268 −
HOMA-IR, homeostasis model assessment of insulin resistance.
Values are Correlation coefficient r (Pearson’s Correlation analysis).
*P< 0.05; **P< 0.01.Cu is a component of antioxidant enzymes that act to
protect the body against the action of free radicals, espe-
cially in cardiovascular diseases. An imbalance in the
metabolism of Cu might trigger hypercholesterolemia
and disorders in oxidative stress [23]. In trace element
metabolism the best known interaction is the reported
antagonism between zinc and copper [24]. The present
study showed that serum Cu level in the obese children
was significantly higher than those in healthy controls
(P < 0.01). This agreed with Lima et al. who reported
that copper concentrations in plasma in the overweight
and obese groups were significantly higher than those in
the control group [25]. The results found by the authors
suggest that excess weight associated with lipid metabol-
ism disorders might predispose to changes in Cu con-
centrations in plasma indicating a possible mechanism
of this mineral, contributing to peroxidation or acting as
an antioxidant. Clouet et al. [26] pointed out that, simi-
lar to iron, copper may also have an indirect impact on
fatty acid oxidation and ATP production in mitochon-
dria, helping the body’s metabolism to break down fatty
acids and reduce fat.
Selenium, which is nutritionally essential for humans,
is a constituent of more than two dozen selenoproteins
(such as glutathione peroxidase GPx and selenoprotein
P). These selenoproteins offer antioxidant protection
against free radicals and other damaging reactive oxygencontrol parameters in obese children and non-obese
Controls (n=80)
MA-IR Glucose Insulin HOMA-IR
0.469* −0.079 −0.063 0.096
0.163 −0.065 0.191 0.234
.635** 0.073 0.144 −0.208
0.148 0.134 −0.235 −0.265
0.123 −0.078 0.156 −0.087
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plications of obesity. In our study obese children had
lower serum selenium levels compared to non-obese
peers (63.6 ± 15 vs 78.3 ± 18 ug/L; P < 0.01). These re-
sults were concordant with a recent study by Ortega
et al., who found that children with excess of weight
have a poorer selenium status than children of normal
weight, which can contribute to poor antioxidant protec-
tion [28]. By contrast, Bouglé et al., reported that none
of their obese subjects did present with low Se levels;
and their overall good Se status is supported by the nor-
mal activity of GPx [17].
In our study, significantly decreased serum Fe levels in
obese children than those of the healthy controls (46.8 ±
11 vs 63.5 ± 13 ug/dl; P < 0.01); were in agreement with
the findings of many other investigators [29,30]. Of note,
there was no significant difference between obese chil-
dren and non-obese peers as regards to serum ferritin
levels (P > 0.05). Previous studies define Fe status by its
serum levels [29,30] when considering ferritin level, the
prevalence of iron deficiency is quite lower. It remains
unclear, however, if the lower serum iron and elevated
ferritin level seen in obesity are most reflective of a func-
tional iron deficiency related to an inflammatory state, or
if obesity is also a risk factor for true iron deficiency [31].
The significance of chromium as a trace nutrient is
well documented and its function in the control of glu-
cose and lipid metabolism has been claimed [32]. Our
results indicated no association between serum chro-
mium levels and obesity.
In our study, obese children have significantly higher
TGs, TC and LDL-C, whereas HDL-C was significantly
lower compared to non-obese peers (P < 0.01). In con-
trast, Woo et al., studied a cohort of obese subjects of
Chinese ethnicity that did not show elevated cholesterol
levels compared to a control group [33]. In addition, our
results indicate that there are only few statistically sig-
nificant correlations between trace elements and lipid
profile was discovered in the obese children while there
is no such correlation in healthy controls. In the obese
children, we observed a significant negative correlation
between serum Zn and TC levels (r = −0.454; P < 0.05)
and a significant positive correlation existed between
serum Zn and HDL-C levels (r = 0.608; P < 0.01); mean-
while the control group showed no such correlation.
These findings indicate the possible effect of Zn level on
serum lipid profile and this effect may be due to the role
of Zn as an antioxidant. Thus, the decrease in Zn level
in obese children may lead to increased lipid peroxida-
tion and leading to increased levels of TC, TG and LDL-C.
These results are concordant with those of a recent report
by Gunasekara et al. who found that treatment with Zn re-
duced TC, TG, and LDL-C plasma levels and increased
HDL-C levels [34].Our data showed no significant correlation between
serum Cu, Se, Fe, Cr and lipid profile parameters in the
obese children (P > 0.05) which confirm the results of
previous studies [17,22].
In our study, association of trace elements levels with
glycaemia control parameters especially HOMA-IR
values was assessed. Negative correlations were found
between serum Zn levels and both fasting glucose and
HOMA-IR in the obese children (r = −0.326, P < 0.05
and r = −0.469, P < 0.05; respectively). Zinc plays a major
role in the stabilization of insulin hexamers and the stor-
age of hormone in the pancreas [35] and its deficiency
seems to impair release of insulin [8]. In the present
study serum Se levels showed significant positive corre-
lations with HOMA-IR values in the obese children (r =
0.635; P < 0.01). These results are concordant with those
of a recent report by Stranges et al., who found a signifi-
cant positive association between plasma Se and glucose
levels at both baseline and follow up. They stated that
high-Se diets may stimulate the release of glucagon,
promoting hyperglycemia, or induce overexpression of
glutathione peroxidase-1 and other antioxidant seleno-
proteins resulting in insulin resistance and obesity [36].
Our study pointed out that the consequences of
changes in serum trace elements during childhood are
much more important for the health of the public than
is generally realized. Trace elements deficiencies may
increase the risk of obesity and related diseases. So im-
proving their status could give an opportunity to influ-
ence the clinical course of obesity [17]. There are some
new studies in literature investigating the serum trace el-
ements in obese adolescents and adults [37,38], However
to the best of our knowledge, this was the first study of
these trace elements in obese Egyptian children. The
small sample size was one of our limitations in this
study; we suggest that multicenter approaches may be
necessary to attain larger sample size. Due to the lack of
evaluations on metabolic risks and pubertal status; as all
our subjects were in the pre pubertal stage, it was not
possible to discuss more interesting and deeper findings.
The lack of longitudinal data showing whether weight
loss can reverse the values of these trace elements; was
another limitation in our study.
Conclusion
The obese children may be at a greater risk of develop-
ing imbalance (mainly deficiency) of trace elements
which may be playing an important role in the patho-
genesis of obesity and related metabolic risk factors.
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